Lymphatic filariasis

Partnership

Partnership is essential for the success of the Global Programme to Eliminate Lymphatic (GPELF) and each individual National Programme (NPELF). Governments initiate and lead national efforts to implement the elimination strategies. Nongovernmental organizations (NGO) support to national governments to facilitate implementation of activities. Bilateral and multilateral donors provide significant financial resources for programme implementation. Pharmaceutical companies are donating the medicines needed for MDA and providing logistical support for the delivery of the medicines to countries and now contributing to the procurement of diagnostics needed to monitor the impact of MDA. Academic institutions and WHO Collaborating Centres, and other support centres are leading research initiatives to provide scientific evidence leading to improved programme strategies and inform WHO guidelines. Donor foundations and government agencies are sponsoring these needed research initiatives. WHO develops the policy and provides guidelines for implementing needed activities, coordinates the donation of medicines and diagnostics and reports progress towards elimination. The Global Alliance to Eliminate Lymphatic Filaraisis (GAELF) provides the forum in which all partners coordinate efforts, engage in advocacy and fundraising to support the aims of GPELF.

By pooling skills and resources and working through national health systems in endemic countries, elimination can be achieved, local capacity strengthened and developmental potential assured for those whose lives would otherwise be blighted by the disease.

In the news